Detalhe da pesquisa
1.
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trial.
Br J Clin Pharmacol
; 90(4): 1081-1093, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105651
2.
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat.
Acta Neuropsychiatr
; 31(4): 213-219, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106729
3.
Reducing the harms of alcohol: nutritional interventions and functional alcohol alternatives.
Int Rev Neurobiol
; 175: 241-276, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555118
4.
Experienced drug users assess the relative harms and benefits of drugs: a web-based survey.
J Psychoactive Drugs
; 45(4): 322-8, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24377171
5.
Psychedelic therapy in the treatment of addiction: the past, present and future.
Front Psychiatry
; 14: 1183740, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377473
6.
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
J Psychopharmacol
; 36(8): 932-942, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924888
7.
The Standard Joint Unit.
Drug Alcohol Depend
; 176: 109-116, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28531767